Walgreens Agrees to $350 Million Settlement Over Opioid Prescription Violations

Walgreens has agreed to a $350 million settlement with the DOJ over claims it unlawfully filled millions of opioid prescriptions between 2012 and 2023. The deal includes a $300 million immediate payment and $50 million contingent on future company transitions. While the company admits no wrongdoing, it has committed to improving compliance with dispensing rules. This settlement closes various opioid-related litigations against Walgreens and is part of broader actions addressing the opioid crisis that has led to over 727,000 deaths in the U.S. since 1999. Efforts include enhancements to Walgreens' prescription validation processes.